919 | RTP
$82.8M INVESTMENT
MISSION TO EMPOWER
Adverum Biotechnologies, a California-based gene therapy company targeting unmet medical needs in ocular and rare diseases, will invest $82.8 million for a new gene therapy manufacturing facility in Research Triangle Park. This investment will create more than 200 new jobs. “Our state’s dynamic workforce continues to propel life-changing innovation and keeps North Carolina at the forefront of biomanufacturing through life sciences companies like Adverum,” said North Carolina Gov. Roy Cooper. Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Positions at the new facility will include production staff, quality control specialists, facility engineers and other personnel and will create an annual payroll impact of $19 million for the Research Triangle region. Adverum Biotechnologies’ new presence in North Carolina will be facilitated, in part, by a Job Development Investment Grant (approved by the state’s Economic Investment
Women in Climate Tech – a new organization with the mission to empower and amplify the voices of women working in the burgeoning industry and to grow the share of females represented who will work on this issue for generations to come – launched earlier this year. WiCT will host monthly members-only networking meetings and will also spearhead pro bono projects with the goal of including climate in STEM education, among other things. Women in Climate Tech will empower and amplify the voices of women working in the industry. Members include engineers, tech executives, communicators, policy specialists, investors, and business leaders. Members of the Steering Committee include: Nicole Efron of PG&E, Rachel Ett of First Solar, Radhika Lalit of Rocky Mountain Institute, Annie Guo of Microsoft, Emily Wasley of WSP, Jennifer Kane of Trane Technologies, and Grace Kankindi. For more information, email Julianne Hogan at julianne@benecomms.io.
A New Group Promotes Women in Climate Tech
Adverum Biotechnologies Plans New RTP Facility
50
www.919Magazine.com
Spring 2021
